Pfizer

Will Dubai's medical tourism sector ever match the more established markets of Singapore and India?

Joanne Bladd reports on the measures the United Arab Emirates is taking to crack down on medication fraud.

The Middle East's dentists are failing to take a proactive role in encouraging their patients to quit smoking, as the number of smokers continues to rise across the region.

The illegal trade in counterfeit medications and the impact it is having on the industry and the people taking it.

Pfizer admits it could take 10 years before cost of generic drugs in region is as low as other parts of world.

Drug advertising is a way of selling sickness, claims Barbara Mintzes. So what regulatory role should governments play in policing promotion?

Significantly more Fibromyalgia patients treated with Pfizer's Lyrica reduced their pain by 50% or more compared with placebo, according to study results presented at the American Academy of Neurology annual meeting.

Pfizer has announced that the U.S. Food and Drug Administration (FDA) has approved Lipitor (atorvastatin calcium) Tablets to reduce the risk of nonfatal heart attacks, fatal and non-fatal strokes, certain types of heart surgery, hospitalisation for heart failure, and chest pain in patients with heart disease.

With UAE regulatory approval in the bag, Medical Times asks: Can Pfizer's US $2 billion diabetes blockbuster live up to the hype?

Pfizer's blockbuster Celebrex (celecoxib) has won FDA approval for pain relief in juvenile rheumatoid arthritis, despite uncertainty about the drug's safety profile in long-term use.